Delivery Order SPE2DB22D2006-SPE2DB23FW2XB
Award Date 9/15/23
Potential Completion Date 9/18/23
Potential Value $1.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,824.74 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 mg/10 ml vials of nalbuphine hydrochloride. The single delivery order is to be performed by Amerisourcebergen's Conshohocken, Pennsylvania facility between July 10-11, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global...
- The Defense Logistics Agency awarded a $6,334 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 mg/10 ml vials of nalbuphine hydrochloride. As the prime contractor, Amerisourcebergen will deliver 10 ml vials of the analgesic drug to a location in Conshohocken, Pennsylvania by July 11, 2023 to support Defense Logistics Agency requirements. The delivery order was issued under an existing DLA pharmaceuticals contract vehicle but did not have any set aside designations....
- The Defense Logistics Agency awarded a $3,086.68 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561538807 Nalbuphine hydrochloride injection, 200 mg/10 mL vials. The single-day contract requires Amerisourcebergen to deliver 10 mL vials of the narcotic analgesic to a facility in Conshohocken, Pennsylvania in support of the Agency's medical supply needs. As a top pharmaceutical distributor, Amerisourcebergen will likely fulfill the order from its existing inventory...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Nalbuphine 100 mg/10 mL vials with a firm fixed price ceiling value of $1,270.82. This is a non-set-aside, competitively awarded contract with an ultimate completion date of September 23, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $7,262.65 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 mg/10 ml vials of nalbuphine hydrochloride. As the prime contractor, Amerisourcebergen will deliver 10 ml vials of the analgesic drug to a location in Conshohocken, Pennsylvania by August 23, 2023 to fulfill DLA's requirements. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a delivery order valued at $1,373.29 to AmerisourceBergen Drug Corp for the supply of Nalbuphine 100 mg/10 mL vials. This competitively awarded, firm fixed-price delivery order was executed on December 2, 2025, with an ultimate completion date of December 3, 2025. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. Nalbuphine is an opioid analgesic used for pain management in military and...
- The Defense Logistics Agency awarded a $614 delivery order to Amerisourcebergen Drug Corporation for 4561422712, which is 100 mg/10 ml vials of nalbuphine hydrochloride. The single order is for 10 ml of the drug and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania under firm fixed pricing with performance and acceptance occurring between July 6-7, 2023. As a pharmaceutical distributor, Amerisourcebergen supports the DLA's medical supply needs through its Prime...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Nalbuphine 100 mg/10 mL vials with a ceiling value of $1,366.25. This firm fixed-price, non-set-aside contract is classified as a delivery order and is scheduled for completion by September 9, 2025. The products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,230.32 to AmerisourceBergen Drug Corp for the supply of Nalbuphine 100 mg/10 ml vials on January 20, 2026, with completion scheduled for January 21, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,845.48 to AmerisourceBergen Drug Corp for the supply of Nalbuphine 100 mg/10 ml vials on December 2, 2025, with an ultimate completion date of December 3, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through...